Literature DB >> 5941276

Stimulation of nonspecific resistance to infection by a crude cell wall preparation from Mycobacterium phlei.

A E Fox, G L Evans, F J Turner, B S Schwartz, A Blaustein.   

Abstract

Fox, Alfred E. (Warner-Lambert Research Institute, Morris Plains, N.J.), George L. Evans, Frank J. Turner, Benjamin S. Schwartz, and Ansel Blaustein. Stimulation of nonspecific resistance to infection by a crude cell wall preparation from Myocobacterium phlei. J. Bacteriol. 92:1-5. 1966.-Exposure of large quantities of viable Mycobacterium phlei to attrition in a colloid mill resulted in 90 to 95% disruption of the organisms. Isolation of the crude cell wall preparation was accomplished by centrifugation of the broken cells at 10,000 x g, resuspension of the sediment, and repeated centrifugation at 1,000 x g to remove intact cells. Single oral or parenteral doses of the cell wall preparation increased the resistance of mice and guinea pigs to experimental infection with Salmonella enteritidis, and of mice to Staphylococcus aureus, for prolonged periods after administration. Histological examination of the organs of mice treated orally or intraperitoneally revealed a lymphoid hyperplasia of the spleen and a Kupffer cell proliferation of the liver. The preparation was nontoxic to mice by the oral route at doses up to 5,000 mg/kg, and the intraperitoneal ld(50) was approximately 680 mg/kg.

Entities:  

Mesh:

Year:  1966        PMID: 5941276      PMCID: PMC276186          DOI: 10.1128/jb.92.1.1-5.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  6 in total

1.  The endotoxins of gram-negative bacteria and host resistance.

Authors:  F S ROSEN
Journal:  N Engl J Med       Date:  1961-05-11       Impact factor: 91.245

2.  Immunogenicity of intracellular particles and cell walls from Mycobacterium tuberculosis.

Authors:  K KANAI; G P YOUMANS
Journal:  J Bacteriol       Date:  1960-11       Impact factor: 3.490

3.  Immunologic significance of the cell wall of mycobacteria.

Authors:  E RIBI; C L LARSON; R LIST; W WICHT
Journal:  Proc Soc Exp Biol Med       Date:  1958-06

4.  STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A MENTHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG). I. ANTIMICROBIAL PROTECTION.

Authors:  D W WEISS; R S BONHAG; J A PARKS
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

5.  Studies on fractions of methanol extracts of tubercle bacilli. I. Fractions which increase resistance to infection.

Authors:  C A WILLIAMS; R J DUBOS
Journal:  J Exp Med       Date:  1959-12-01       Impact factor: 14.307

6.  Effects of cellular constituents of mycobacteria on the resistance of mice to heterologous infections I. Protective effects.

Authors:  R J DUBOS; R W SCHAEDLER
Journal:  J Exp Med       Date:  1957-11-01       Impact factor: 14.307

  6 in total
  4 in total

1.  Isolation of a Soluble Resistance-Enhancing Factor from Mycobacterium phlei.

Authors:  A E Fox; J Anschel; G L Evans; R R Mohan; B S Schwartz
Journal:  J Bacteriol       Date:  1966-08       Impact factor: 3.490

Review 2.  BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.

Authors:  Wenping Gong; Yingqing Mao; Yuexi Li; Yong Qi
Journal:  Int Immunopharmacol       Date:  2022-05-17       Impact factor: 5.714

Review 3.  Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.

Authors:  Kanak Parmar; Afzal Siddiqui; Kenneth Nugent
Journal:  Am J Med Sci       Date:  2021-03-08       Impact factor: 2.378

4.  The Effect of Inactivated Mycobacterium Paratuberculosis Vaccine on the Response to a Heterologous Bacterial Challenge in Pigs.

Authors:  Kristoffer Jarlov Jensen; Mette Sif Hansen; Peter Mikael Helweg Heegaard; Christine Stabell Benn; Gregers Jungersen
Journal:  Front Immunol       Date:  2019-07-05       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.